DYNAMIC OPTIMIZED PRIORS FOR D-BAR RECONSTRUCTIONS OF HUMAN VENTILATION USING ELECTRICAL IMPEDANCE TOMOGRAPHY

Por ALSAKER, MELODY, MUELLER, JENNIFER L., MURTHY, RASHMI
Publicado no J Comput Appl Math (2018)

A DIRECT RECONSTRUCTION ALGORITHM FOR THE ANISOTROPIC INVERSE CONDUCTIVITY PROBLEM BASED ON CALDERÓN’S METHOD IN THE PLANE

Por MURTHY, RASHMI, LIN, YI-HSUAN, SHIN, KWANCHEOL, MUELLER, JENNIFER L.
Publicado no Inverse Probl (2020)

Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer

Por Barcenas, Carlos H., Shafaee, Maryam N., Sinha, Arup K., Raghavendra, Akshara, Saigal, Babita, Murthy, Rashmi K., Woodson, Ashley H., Arun, Banu
Publicado no J Natl Compr Canc Netw (2018)

Estimating regions of air trapping from electrical impedance tomography data

Por Mueller, Jennifer L., Muller, Peter, Mellenthin, Michelle, Murthy, Rashmi, Capps, Michael, Alsaker, Melody, Deterding, Robin, Sagel, Scott D., DeBoer, Emily
Publicado no Physiol Meas (2018)

Evaluation of surrogate measures of pulmonary function derived from electrical impedance tomography data in children with cystic fibrosis

Por Muller, Peter, Mueller, Jennifer L., Mellenthin, Michelle, Murthy, Rashmi, Capps, Michael, Wagner, Brandie D., Alsaker, Melody, Deterding, Robin, Sagel, Scott D., Hoppe, Jordana
Publicado no Physiol Meas (2018)

T-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancers That Received Prior Therapy With Trastuzumab and Pertuzumab

Por Dzimitrowicz, Hannah, Berger, Michael, Vargo, Craig, Hood, Annette, Abdelghany, Osama, Raghavendra, Akshara Singareeka, Tripathy, Debu, Valero, Vicente, Hatzis, Christos, Pusztai, Lajos, Murthy, Rashmi
Publicado no J Clin Oncol (2016)

Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

Por Meric-Bernstam, Funda, Johnson, Amber M., Dumbrava, Ecaterina E. Ileana, Raghav, Kanwal P., Balaji, Kavitha, Bhatt, Michelle, Murthy, Rashmi K., Rodon, Jordi, Piha-Paul, Sarina A.
Publicado no Clin Cancer Res (2018)

Outcomes of children exposed in utero to chemotherapy for breast cancer

Por Murthy, Rashmi K, Theriault, Richard L, Barnett, Chad M, Hodge, Silvia, Ramirez, Mildred M, Milbourne, Andrea, Rimes, Sue A, Hortobagyi, Gabriel N, Valero, Vicente, Litton, Jennifer K
Publicado no Breast Cancer Res (2014)

Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice

Por Murthy, Rashmi K., Song, Juhee, Raghavendra, Akshara S., Li, Yisheng, Hsu, Limin, Hess, Kenneth R., Barcenas, Carlos H., Valero, Vicente, Carlson, Robert W., Tripathy, Debu, Hortobagyi, Gabriel N.
Publicado no NPJ Breast Cancer (2020)

Long‐Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2‐Targeted Therapy

Por Wong, Yao, Raghavendra, Akshara Singareeka, Hatzis, Christos, Irizarry, Javier Perez, Vega, Teresita, Horowitz, Nina, Barcenas, Carlos H., Chavez‐MacGregor, Mariana, Valero, Vicente, Tripathy, Debu, Pusztai, Lajos, Murthy, Rashmi K.
Publicado no Oncologist (2018)

Prognostic Value of HER2 to CEP17 Ratio on Fluorescence In Situ Hybridization Ratio in Patients with Nonmetastatic HER2‐Positive Inflammatory and Noninflammatory Breast Cancer Trea...

Por Kogawa, Takahiro, Fujii, Takeo, Wu, Jimin, Harano, Kenichi, Fouad, Tamer M., Liu, Diane D., Shen, Yu, Masuda, Hiroko, Krishnamurthy, Savitri, Chavez‐MacGregor, Mariana, Lim, Bora, Murthy, Rashmi K., Valero, Vicente, Tripathy, Debu, Ueno, Naoto T.
Publicado no Oncologist (2020)

LPTO-08. INTRATHECAL TRASTUZUMAB PLUS/MINUS IT TOPOTECAN FOR PATIENTS WITH HER2+ BREAST CANCER AND LEPTOMENINGEAL METASTASIS

Por Trevino, Christopher R, Murthy, Rashmi K, Raghavendra, Akshara Singareeka, Loghin, Monica, Seligman, Christa, Ferguson, Sherise, Kamiya-Matsuoka, Carlos, Harrison, Rebecca, Sinicrope, Kaylyn D, Valero, Vicente, Tummala, Sudhakar, Hess, Kenneth, Tripathy, Debu, de Groot, John, O’Brien, Barbara
Publicado no Neurooncol Adv (2019)

Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low–Expressing Advanced Breast Cancer: Results From a Phase Ib Study

Por Modi, Shanu, Park, Haeseong, Murthy, Rashmi K., Iwata, Hiroji, Tamura, Kenji, Tsurutani, Junji, Moreno-Aspitia, Alvaro, Doi, Toshihiko, Sagara, Yasuaki, Redfern, Charles, Krop, Ian E., Lee, Caleb, Fujisaki, Yoshihiko, Sugihara, Masahiro, Zhang, Lin, Shahidi, Javad, Takahashi, Shunji
Publicado no J Clin Oncol (2020)

53. TUCATINIB VS PLACEBO ADDED TO TRASTUZUMAB AND CAPECITABINE FOR PATIENTS WITH PREVIOUSLY TREATED HER2+ METASTATIC BREAST CANCER (MBC) WITH BRAIN METASTASES (BM) (HER2CLIMB)

Por Lin, Nancy, Murthy, Rashmi, Anders, Carey, Borges, Virginia, Hurvitz, Sara, Loi, Sherene, Abramson, Vandana, Bedard, Philippe, Oliveira, Mafalda, Zelnack, Amelia, DiGiovanna, Michael, Bachelot, Thomas, Chien, A Jo, O’Regan, Ruth, Wardley, Andrew, Mueller, Volkmar, Carey, Lisa, McGoldrick, Suzanne, An, Xuebei, Winer, Eric
Publicado no Neurooncol Adv (2020)

Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer

Por Basho, Reva K., Yam, Clinton, Gilcrease, Michael, Murthy, Rashmi K., Helgason, Thorunn, Karp, Daniel D., Meric‐Bernstam, Funda, Hess, Kenneth R., Valero, Vicente, Albarracin, Constance, Litton, Jennifer K., Chavez‐MacGregor, Mariana, Hong, David, Kurzrock, Razelle, Hortobagyi, Gabriel N., Janku, Filip, Moulder, Stacy L.
Publicado no Oncologist (2018)

CTNI-02. TBCRC049: A PHASE II STUDY TO ASSESS THE SAFETY AND EFFICACY OF THE COMBINATION OF TUCATINIB, TRASTUZUMAB AND CAPECITABINE FOR THE TREATMENT OF LEPTOMENINGEAL METASTASIS I...

Por Murthy, Rashmi, O’Brien, Barbara, Berry, Donald, Navin, Nicholas, Johnson, Jason, Gule-Monroe, Maria, Leone, Jose, Specht, Jennifer, Melisko, Michelle, Morikawa, Aki, Storniolo, Anna, Brufsky, Adam, Pohlmann, Paula, Park, Deric, Park, Ben, Krop, Ian, Lin, Nancy, Rimawi, Mothaffar, Wolff, Antonio, Forero-Torres, Andres, Stringer-Reasor, Erica
Publicado no Neuro Oncol (2020)

LPTO-09. INTRATHECAL TOPOTECAN FOR LEPTOMENINGEAL METASTASIS IN SOLID TUMORS: THE MD ANDERSON EXPERIENCE

Por Sinicrope, Kaylyn D, Barata, Pedro, Walker, Julie, Tremont-Lukats, Ivo W, Groves, Morris, Loghin, Monica, Seligman, Christa, Ferguson, Sherise, Weathers, Shiao-Pei, Penas-Prado, Marta, Kamiya-Matsuoka, Carlos, Harrison, Rebecca, Tummala, Sudhakar, Trevino, Christopher R, Peinado, Shanta, Murthy, Rashmi K, Seyedeh, Dibaj, de Groot, John, O’Brien, Barbara
Publicado no Neurooncol Adv (2019)

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment

Por Lim, Bora, Murthy, Rashmi K., Lee, Jangsoon, Jackson, Summer A., Iwase, Toshiaki, Davis, Darren W., Willey, Jie S., Wu, Jimin, Shen, Yu, Tripathy, Debu, Alvarez, Ricardo, Ibrahim, Nuhad K., Brewster, Abenaa M., Barcenas, Carlos H., Brown, Powel H., Giordano, Sharon H., Moulder, Stacy L., Booser, Daniel J., Moscow, Jeffrey A., Piekarz, Richard, Valero, Vicente, Ueno, Naoto T.
Publicado no Br J Cancer (2019)

Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant

Por Litton, Jennifer K., Scoggins, Marion E., Hess, Kenneth R., Adrada, Beatriz E., Murthy, Rashmi K., Damodaran, Senthil, DeSnyder, Sarah M., Brewster, Abenaa M., Barcenas, Carlos H., Valero, Vicente, Whitman, Gary J., Schwartz-Gomez, Jill, Mittendorf, Elizabeth A., Thompson, Alastair M., Helgason, Thorunn, Ibrahim, Nuhad, Piwnica-Worms, Helen, Moulder, Stacy L., Arun, Banu K.
Publicado no J Clin Oncol (2020)

SET(ER/PR): a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer

Por Sinn, Bruno V., Fu, Chunxiao, Lau, Rosanna, Litton, Jennifer, Tsai, Tsung-Heng, Murthy, Rashmi, Tam, Alda, Andreopoulou, Eleni, Gong, Yun, Murthy, Ravi, Gould, Rebekah, Zhang, Ya, King, Tari A., Viale, Agnes, Andrade, Victor, Giri, Dilip, Salgado, Roberto, Laios, Ioanna, Sotiriou, Christos, Marginean, Esmeralda C., Kwiatkowski, Danielle N., Layman, Rachel M., Booser, Daniel, Hatzis, Christos, Vicente Valero, V., Fraser Symmans, W.
Publicado no NPJ Breast Cancer (2019)